- Home
- IGC vs BCHT Comparison
IGC vs BCHT Comparison
Compare IGC & BCHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IGC | BCHT |
|---|---|---|
| Founded | 2005 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.0M | 36.6M |
| IPO Year | 2005 | 2016 |
Fundamental Metrics
Financial Performance| Metric | IGC | BCHT |
|---|---|---|
| Price | $0.25 | $1.12 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 590.3K | 126.5K |
| Earning Date | 11-05-2026 | 11-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 59.09 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,271,000.00 | ★ $17,626,366.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $73.49 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 1.26 |
| 52 Week Low | $0.24 | $1.12 |
| 52 Week High | $0.45 | $2.59 |
Technical Indicators
Market Signals| Indicator | IGC | BCHT |
|---|---|---|
| Relative Strength Index (RSI) | 37.51 | 31.15 |
| Support Level | $0.24 | $1.14 |
| Resistance Level | $0.30 | $1.54 |
| Average True Range (ATR) | 0.01 | 0.09 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 22.55 | 10.26 |
Price Performance
Historical ComparisonAbout IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.
About BCHT Birchtech Corp. Common Stock
Birchtech Corp is a provider of specialty activated carbon technologies, delivering solutions for air and water purification. It provides patented and proprietary Sorbent Enhancement Additive (SEA) technologies for mercury emissions capture to the coal-fired utility sector, and is developing water purification technologies with a specialization on forever chemicals such as PFAS and PFOS. Geographically, the company derives all of its revenue from the United States.